Roche could have Indian competition for Herceptin sooner than it thought. Now that the Swiss drugmaker has decided to forego a patent fight over the breast cancer drug in India, domestic drugmakers are rubbing their hands together in anticipation.
Israeli oral drug delivery developer Oramed began recruiting patients for a clinical trial of its oral insulin pill for patients with Type 1 diabetes mellitus.
A new Australian 7-year study showed that insulin pumps improved glycemic control and reduced hypoglycemia compared with insulin injections among children with Type I diabetes. It was the largest study of insulin pump use in children and had the longest follow-up period of any study to date.
Scientists at the Indiana University School of Medicine said they've spotted 6 blood-based clues they believe could serve as viable predictors of suicide, led by the enzyme SAT1.
Plans are in place to use the money to back development of the company's 3-D mapping system designed to spot the source of irregular heartbeats and guide treatment.
When Merck cut its sales guidance last month, market-watchers predicted cost cuts. Soon, executives would be sharpening their scalpels--or heavier instruments--to compensate. After all, generic competition isn't going away, and the company's pipeline has taken some embarrassing hits of late.
During Merck's last quarterly call, R&D chief Roger Perlmutter discussed cautiously reducing R&D spending by about $144 million this year. But Leerink Swann's Seamus Fernandez thinks a major restructuring is in order.
Fragments freed by the breakdown of the lungs' key proteins in tuberculosis patients may prove to be promising new biomarkers for the disease in a number of ways, U.K. and South African researchers have concluded in a new study.
In a move that boosted the fortunes of two biotech outfits, Pfizer has elected to continue development of the tamper-resistant painkiller Remoxy with a planned Phase I study, Nasdaq reported.
Two research teams, in separate projects, hope to advance the development of a viable artificial pancreas system through a smartphone app and a wireless sensor placed in blood vessels.